Anesthetic management of hepatic transplantation

Current Opinion in Anaesthesiology

Volumn 21, Issue 3, 2008, Pages 391-400

  Ozier, Yves ^a   Klinck, John R ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Anesthesia; Hepatic insufficiency; Intensive care; Liver diseases; Liver failure; Liver transplantation

Indexed keywords

ANESTHETIC AGENT; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN; APROTININ; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FENOLDOPAM; FRESH FROZEN PLASMA; FUROSEMIDE; GLUCOSE; HEPARIN; HYPERTENSIVE FACTOR; INSULIN; ISOSORBIDE 5 NITRATE; MANNITOL; NITRIC OXIDE; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; PLASMA SUBSTITUTE; POTASSIUM; PROSTACYCLIN; PROTAMINE; PROTEIN C; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SALBUTAMOL; STEROID; TERLIPRESSIN; TRANEXAMIC ACID; UNINDEXED DRUG; VON WILLEBRAND FACTOR;

ANESTHESIA; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN HERNIA; BRAIN PERFUSION; CARDIOMYOPATHY; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; ELECTROLYTE DISTURBANCE; EXTUBATION; FIBRINOLYTIC THERAPY; FLUID RESUSCITATION; GRAFT PERFUSION; HEART CATHETERIZATION; HEART VENTRICLE FIBRILLATION; HEMATOLOGIC DISEASE; HEMODIAFILTRATION; HEMODYNAMIC MONITORING; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOKALEMIA; HYPOTENSION; HYPOVOLEMIA; INTERNATIONAL NORMALIZED RATIO; INTRACARDIAC THROMBOSIS; INTRACRANIAL PRESSURE MONITORING; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY INJURY; LIVER FAILURE; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUNG EMBOLISM; MINIMALLY INVASIVE SURGERY; MULTIPLE ORGAN FAILURE; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PATIENT SAFETY; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PHLEBOTOMY; PORTOPULMONARY HYPERTENSION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTHROMBIN TIME; REPERFUSION; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; REVIEW; SEPSIS; SURGICAL PATIENT; SURGICAL RISK; THROMBECTOMY; THROMBOCYTOPATHY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VOLUME RESTRICTIVE SUBSTITUTION THERAPY;

ANESTHESIA, GENERAL; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; HEMODYNAMICS; HUMANS; HYPERKALEMIA; LIVER FAILURE; LIVER TRANSPLANTATION; MONITORING, INTRAOPERATIVE; PREOPERATIVE CARE;

EID: 43149109275     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3282ff85f4     Document Type: Review

References (100)

1. Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59:859-864.
2. Plotkin JS, Scott VL, Pinna A, et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2:426-430.
3. Ben Ari A, Elinav E, Elami A, et al. Off-pump coronary artery bypass grafting in a patient with Child class C liver cirrhosis awaiting liver transplantation. Br J Anaesth 2006; 97:468-472.
4. Pollard RJ, Sidi A, Gibby GL, et al. Aortic stenosis with end-stage liver disease: prioritizing surgical and anesthetic therapies. J Clin Anesth 1998; 10:253-261.
5. Cywinski JB, Argalious M, Marks TN, et al. Dynamic left ventricular outflow tract obstruction in an orthotopic liver transplant recipient. Liver Transpl 2005; 11:692-695.
6. Aniskevich S, Shine TS, Feinglass NG, et al. Dynamic left ventricular outflow tract obstruction during liver transplantation: the role of transesophageal echocardiography. J Cardiothorac Vasc Anesth 2007; 21:577-580.
7. Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6:443-450.
8. Ramsay MA. Perioperative mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6:451-452.
9. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10:174-182.
10. Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006; 44:1502-1510. This is the largest cohort of PPHTN cases analyzed to date. The limitations of screening echocardiography are highlighted together with the necessity for right heart catheterization to accurately characterize pulmonary hemodynamics. The investigators advocate a screening echocardiographic RVsyst cutoff of 50mmHg for invasive measurements. A stratification of hemodynamic subgroups based on resistance, pressure, flow, and volume is proposed. The study supports the lack of correlation between MELD score and pulmonary hemodynamics.
11. Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003; 37:401-409.
12. Rodriguez-Roisin R, Krowka MJ, Herve P, et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24:861-880.
13. Cotton CL, Gandhi S, Vaitkus PT, et al. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl 2002; 8:1051-1054.
14. Farzaneh-Far R, McKeown BH, Dang D, et al. Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol 2008; 101:259-262.
15. Mandell MS. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl 2004; 10:S54-S58.
16. Fix OK, Bass NM, De Marco T, et al. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl 2007; 13:875-885.
17. Ricci GL, Melgosa MT, Burgos F, et al. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension. Liver Transpl 2007; 13:1506-1514.
18. Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 2007; 46:727-733.
19. Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44:53-61.
20. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41:553-558.
21. Lisman T, Leebeek FW, Mosnier LO, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 2001; 121:131-139.
22. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006; 6:2651-2659.
23. Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl 2002; 8:91-109.
24. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003; 37:233-243.
25. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23:164-176.
26. Gines P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet 2003; 362:1819-1827.
27. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41:1282-1289.
28. Restuccia T, Ortega R, Guevara M, et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome: a casecontrol study. J Hepatol 2004; 40:140-146.
29. Marik P, Wood K, Starzl T. The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 2006; 21:478-482.
30. Ruiz R, Barri YM, Jennings LW, et al. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl 2007; 13:838-843.
31. O'Riordan A, Wong V, McQuillan R, et al. Acute renal disease, as defined by the RIFLE criteria, postliver transplantation. Am J Transplant 2007; 7:168-176.
32. Swygert TH, Roberts LC, Valek TR, et al. Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 1991; 75:571-576.
33. Della Rocca G, Pompei L, Costa MG, et al. Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial. Anesth Analg 2004; 99:1604-1609.
34. Biancofiore G, Della Rocca G, Bindi L, et al. Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl 2004; 10:986-992.
35. Brienza N, Malcangi V, Dalfino L, et al. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 2006; 34:707-714.
36. Bernuau J, Durand F. Intracranial pressure monitoring in patients with acute liver failure: a questionable invasive surveillance. Hepatology 2006; 44:502-504.
37. Wendon JA, Larsen FS. Intracranial pressure monitoring in acute liver failure: a procedure with clear indications. Hepatology 2006; 44:504-506.
38. Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11:1581-1589.
39. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35:2498-2508.
40. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005; 11:594-605.
41. Reich DL, Wood RK, Emre S, et al. Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2003; 17:699-702.
42. Barnett R. Pro: veno-veno bypass should routinely be used during liver transplantation. J Cardiothorac Vasc Anesth 2006; 20:742-743.
43. Hilmi I, Planinsic R. Con: venovenous bypass should not be used in orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2006; 20:744-747.
44. Budd J, Isaac J, Bennett J, et al. Morbidity and mortality associated with large-bore percutaneous venovenous bypass cannulation for 312 orthotopic liver transplantations. Liver Transpl 2001; 7:359-362.
45. Schumann R. Intraoperative resource utilization in anesthesia for liver transplantation in the United States: a survey. Anesth Analg 2003; 97:21-28.
46. Aggarwal S, Kang Y, Freeman JA, et al. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987; 19:54-55.
47. Ducerf C, Mechet I, Landry JL, et al. Hemodynamic profiles during piggyback liver grafts using arterial or portal revascularization. J Am Coll Surg 2000; 190:89-93.
48. Walsh TS, Garden OJ, Lee A. Metabolic, cardiovascular, and acid-base status after hepatic artery or portal vein reperfusion during orthotopic liver transplantation. Liver Transpl 2002; 8:537-544.
49. Moreno C, Sabate A, Figueras J, et al. Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: influence of hepatic artery or portal vein revascularization of the graft. Liver Transpl 2006; 12:1607-1614.
50. Arnal D, Garutti I, Perez-Pena J, et al. Radial to femoral arterial blood pressure differences during liver transplantation. Anaesthesia 2005; 60:766-771.
51. Findlay J, Gali B, Keegan M, et al. Vasotrac arterial blood pressure and direct arterial blood pressure monitoring during liver transplantation. Anesth Analg 2006; 102:690-693.
52. Greim CA, Roewer N, Thiel H, et al. Continuous cardiac output monitoring during adult liver transplantation: thermal filament technique versus bolus thermodilution. Anesth Analg 1997; 85:483-488.
53. Bottiger BW, Sinner B, Motsch J, et al. Continuous versus intermittent thermodilution cardiac output measurement during orthotopic liver transplantation. Anaesthesia 1997; 52:207-214.
54. Gwak MS, Kim JA, Kim GS, et al. Incidence of severe ventricular arrhythmias during pulmonary artery catheterization in liver allograft recipients. Liver Transpl 2007; 13:1451-1454.
55. Burtenshaw AJ, Isaac JL. The role of trans-oesophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation. Liver Transpl 2006; 12:1577-1583. After a detailed review of the rationale for an effective cardiovascular monitoring tool during the OLT procedure, this article appraises the value of TOE. The potential advantages and complications of the technique are compared with the traditional pulmonary artery catheter.
56. Colbert S, O'Hanlon D, Duranteau J, et al. Cardiac output during liver transplantation. Can J Anaesth 1998; 45:133-138.
57. Della Rocca G, Costa M, Pompei L, et al. Continuous and intermittent cardiac output measurement: pulmonary artery catheter versus aortic transpulmonary technique. Br J Anaesth 2002; 88:350-356.
58. Murphy N, Auzinger G, Bernel W,et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39:464-470.
59. Nakasuji M, Bookallil M. Pathophysiological mechanisms of postrevascularization hyperkalemia in orthotopic liver transplantation. Anesth Analg 2000; 91:1351-1355.
60. Ziemann-Gimmel P, Pygon B, Hurley F, et al. Treatment of life-threatening hyperkalemia using hemoconcentration in parallel to venovenous bypass during orthotopic liver transplantation. Anesth Analg 2003; 96:680-682.
61. Nakagawa M, Kubota M, Endo I, et al. Use of a K(+)-adsorption filter for the massive transfusion of irradiated red blood cells in a child. Can J Anaesth 2004; 51:639-640.
62. Xia VW, Ghobrial RM, Du B, et al. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007; 105:780-785. This retrospective study of a large cohort of adult cases (including cardiac death and living donor OLT) helps to identify patients in whom a preventive therapy of hyperkalemia should be initiated. Models including baseline hyperkalemia, intraoperative variables and donor characteristics are developed for the prediction of hyperkalemia during the different stages of the procedure. A rather unexpected variable is the use of VVBP.
63. Xia VW, Du B, Tran A, et al. Intraoperative hypokalemia in pediatric liver transplantation: incidence and risk factors. Anesth Analg 2006; 103:587-593. Unlike adults, pediatric recipients are prone to intraoperative hypokalemia during OLT, as shown in this series of 268 cases. The reasons for this difference are unclear, but some risk factors can be identified.
64. Moreno-Gonzalez E, Meneu-Diaz JG, Fundora Y, et al. Advantages of the piggy back technique on intraoperative transfusion, fluid compsumption, and vasoactive drugs requirements in liver transplantation: a comparative study. Transplant Proc 2003; 35:1918-1919.
65. Figueras J, Llado L, Ramos E, et al. Temporary portocaval shunt during liver transplantation with vena cava preservation: results of a prospective randomized study. Liver Transpl 2001; 7:904-911.
66. Suarez-Munoz MA, Santoyo J, Fernandez-Aguilar JL, et al. Transfusion requirements during liver transplantation: impact of a temporary portacaval shunt. Transplant Proc 2006; 38:2486-2487.
67. Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007; 7:185-194.
68. Ozier Y, Pessione F, Samain E, et al. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003; 97:671-679.
69. McCluskey SA, Karkouti K, Wijeysundera DN, et al. Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation. Liver Transpl 2006; 12:1584-1593.
70. Xia VW, Du B, Braunfeld M, et al. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl 2006; 12:614-620.
71. Massicotte L, Sassine MP, Lenis S, et al. Transfusion predictors in liver transplant. Anesth Analg 2004; 98:1245-1251.
72. Coakley M, Reddy K, Mackie I, et al. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006; 20:548-553. This interesting paper shows that perioperative transfusion practices in liver transplantation are likely to differ according to the method of coagulation monitoring used. The greatest variability in fulfilling transfusion criteria between coagulation monitoring systems occurred for transfusion of fresh frozen plasma.
73. Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9:1320-1327.
74. de Boer MT, Christensen MC, Asmussen M, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106:32-44. As earlier studies have shown, this retrospective study of 433 adult cases between 1989 and 2004 indicates that RBCs transfusions are an independent risk factor for survival following OLT. A remarkable point is the negative impact of platelet transfusion on survival shown by propensity-adjusted analysis. Transfusion of platelets and RBCs is highly dominant in predicting 1- year patient survival. Interestingly, the blood-sparing effect of antifibrinolytic therapy does not appear to have influenced survival in univariate analysis.
75. Reyle-Hahn M, Rossaint R. Coagulation techniques are not important in directing blood product transfusion during liver transplantation. Liver Transpl Surg 1997; 3:659-663; discussion 663-655.
76. Massicotte L, Lenis S, Thibeault L, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12:117-123. The authors report that 79% of a series of almost 100 cases could be performed without the use for any blood products, provided the patient's CVP is kept low through restriction of volume replacement, elimination of all plasma transfusion, and eventually by using intra-operative phlebotomy. Blood salvage and low RBC transfusion trigger are also used. This strategy was apparently not damaging to renal function or to other vital systems. These data give points to arguments against aggressive volume and product use. They have been hotly debated, however, especially regarding the mean MELD scores at operation that seem lower than those at some other centers, and clearly need confirmation.
77. Kiszka-Kanowitz M, Henriksen JH, Moller S, et al. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol 2001; 35:605-612.
78. Schroeder R, Collins B, Tuttle-Newhall E, et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2004; 18:438-441.
79. Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 2000; 355:1303-1309.
80. Dalmau A, Sabate A, Acosta F, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000; 91:29-34.
81. Dalmau A, Sabate A, Koo M, et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 2004; 10:279-284.
82. Ickx BE, van der Linden PJ, Melot C, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion 2006; 46:595-605.
83. Planinsic RM, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005; 11:895-900.
84. Lodge JP, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005; 11:973-979.
85. Niemann CU, Behrends M, Quan D, et al. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med 2006; 16:93-100.
86. Kang YG, Martin DJ, Marquez JM, et al. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 1985; 64:888-896.
87. Gologorsky E, De Wolf A, Scott V, et al. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl 2001; 7:783-789.
88. Warnaar N, Molenaar IQ, Colquhoun SD, et al. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. J Thromb Haemost 2007; 6:297-302. The authors have identified 74 published OLT cases complicated by intraoperative pulmonary embolism and intracardiac thrombosis, and they have studied the clinical presentation, the outcome, and potential risk factors. None of the usual putative risk factors appeared to be universally present, suggesting a multifactorial pathogenesis. A valuable contribution to the knowledge of this dreadful complication.
89. Ramsay M, Randall H, Burton E. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated? Liver Transpl 2004; 10:310-314.
90. Jackson D, Botea A, Gubenko Y, et al. Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis. Anesth Analg 2006; 102:724-728.
91. Planinsic R, Nicolau-Raducu R, Eghtesad B, et al. Diagnosis and treatment of intracardiac thrombosis during orthotopic liver transplantation. Anesth Analg 2004; 99:353-356.
92. Ellenberger C, Mentha G, Giostra E, et al. Cardiovascular collapse due to massive pulmonary thromboembolism during orthotopic liver transplantation. J Clin Anesth 2006; 18:367-371.
93. Mandell MS, Lockrem J, Kelley SD. Immediate tracheal extubation after liver transplantation: experience of two transplant centers. Anesth Analg 1997; 84:249-253.
94. Mandell M, Lezotte D, Kam I, et al. Reduced use of intensive care after liver transplantation: influence of early extubation. Liver Transpl 2002; 8:676-681.
95. Biancofiore G, Romanelli A, Bindi M, et al. Very early tracheal extubation without predetermined criteria in a liver transplant recipient population. Liver Transpl 2001; 7:777-782.
96. Glanemann M, Langrehr J, Kaisers U, et al. Postoperative tracheal extubation after orthotopic liver transplantation. Acta Anaesthesiol Scand 2001; 45:333-339.
97. Findlay JY, Jankowski CJ, Vasdev GM, et al. Fast track anesthesia for liver transplantation reduces postoperative ventilation time but not intensive care unit stay. Liver Transpl 2002; 8:670-675.
98. Mandell MS, Stoner TJ, Barnett R, et al. A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl 2007; 13:1557-1563. This large and multiinstitutional study has gathered information on the frequency, type, severity, and risk factors of adverse outcomes following early extubation as well as on differences between seven institutions using the same criteria. Adverse events were uncommon, usually pulmonary or surgically related. Variables associated with adverse events were the number of units of blood transfused, the piggyback technique, and the use of VVBP, but this does not imply a causal link. Marked unexplained interinstitutional differences are noted.
99. Mandell M, Hang Y. Pro: early extubation after liver transplantation. J Cardiothorac Vasc Anesth 2007; 21:752-755.
100. Steadman R. Con: immediate extubation for liver transplantation. J Cardiothorac Vasc Anesth 2007; 21:756-757.